Clinical verification of (18)F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer

PURPOSE: Radiolabeled Prostate-Specific Membrane Antigen (PSMA) PET/CT is the current standard-of-care for lesion detection in patients with biochemically recurrent (BCR) prostate cancer (PCa). However, rigorous verification of detected lesions is not always performed in routine clinical practice. T...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Meijer, Dennie, Jansen, Bernard H. E., Wondergem, Maurits, Bodar, Yves J. L., Srbljin, Sandra, Vellekoop, Annelies E., Keizer, Bram, van der Zant, Friso M., Hoekstra, Otto S., Nieuwenhuijzen, Jakko A., Dahele, Max, Vis, André N., Oprea-Lager, Daniela E.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537873/
https://ncbi.nlm.nih.gov/pubmed/33021980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0239414
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki